Reinfection and reactivation of SARS-CoV-2
- PMID: 36176508
- PMCID: PMC9514089
- DOI: 10.2217/fvl-2021-0212
Reinfection and reactivation of SARS-CoV-2
Abstract
As the cases of SARS-CoV-2 infection escalates, the essence of in-depth knowledge around acquired immunity and emergence of reinfection and reactivation have to be captured. While being a rare phenomenon, reinfection occurs as the result of diminishing protection conferred by antibodies, especially IgG. Reactivation is more concerned with the role of various elements including shedding lingering viral RNA for a prolonged time and incomplete resolution of infection along with the insight of dormant viral exosomes' role. The concept of testing positive after two consecutive negative results requires proper discrimination of reinfection from reactivation. In this review, we summarized the current evidence for possible mechanisms leading to viral reactivation or test re-positivity. We also pointed out risk factors associated with both reinfection and reactivation.
Keywords: COVID-19; SARS-CoV-2; reactivation; reinfection.
© 2022 Future Medicine Ltd.
Similar articles
-
Reinfection of SARS-CoV-2 - analysis of 23 cases from the literature.Infect Dis (Lond). 2021 Jul;53(7):479-485. doi: 10.1080/23744235.2021.1905174. Epub 2021 Apr 13. Infect Dis (Lond). 2021. PMID: 33849385 Free PMC article.
-
Clinical characteristics of SARS-CoV-2 by re-infection vs. reactivation: a case series from Iran.Eur J Clin Microbiol Infect Dis. 2021 Aug;40(8):1713-1719. doi: 10.1007/s10096-021-04221-6. Epub 2021 Mar 18. Eur J Clin Microbiol Infect Dis. 2021. PMID: 33738620 Free PMC article.
-
On the potential role of exosomes in the COVID-19 reinfection/reactivation opportunity.J Biomol Struct Dyn. 2021 Sep;39(15):5831-5842. doi: 10.1080/07391102.2020.1790426. Epub 2020 Jul 9. J Biomol Struct Dyn. 2021. PMID: 32643586 Free PMC article.
-
Differentials of SARS-CoV-2 Viral RNA Re-positivity in Discharged COVID-19 Patients.AIDS Rev. 2021 Jun 3;23(3):153-163. doi: 10.24875/AIDSRev.21000023. AIDS Rev. 2021. PMID: 34082440 Review.
-
COVID-19 reinfection: the role of natural immunity, vaccines, and variants.J Community Hosp Intern Med Perspect. 2021 Nov 15;11(6):733-739. doi: 10.1080/20009666.2021.1974665. eCollection 2021. J Community Hosp Intern Med Perspect. 2021. PMID: 34804382 Free PMC article. Review.
Cited by
-
Structure-based virtual identification of natural inhibitors of SARS-CoV-2 and its Delta and Omicron variant proteins.Future Virol. 2023 May;18(7):421-438. doi: 10.2217/fvl-2022-0184. Epub 2023 Jun 1. Future Virol. 2023. PMID: 38051986 Free PMC article.
-
Hematological, inflammatory, and novel biomarkers assessment as an eminent strategy for clinical management of COVID-19.Heliyon. 2023 Nov 28;9(12):e22896. doi: 10.1016/j.heliyon.2023.e22896. eCollection 2023 Dec. Heliyon. 2023. PMID: 38076059 Free PMC article.
-
Towards Understanding Long COVID: SARS-CoV-2 Strikes the Host Cell Nucleus.Pathogens. 2023 Jun 6;12(6):806. doi: 10.3390/pathogens12060806. Pathogens. 2023. PMID: 37375496 Free PMC article. Review.
-
A Tiny Viral Protein, SARS-CoV-2-ORF7b: Functional Molecular Mechanisms.Biomolecules. 2024 Apr 30;14(5):541. doi: 10.3390/biom14050541. Biomolecules. 2024. PMID: 38785948 Free PMC article.
-
In silico identification of deep-sea fungal alkaloids as potential inhibitors of SARS-CoV-2, Delta and Omicron spikes.Future Virol. 2023 Oct:10.2217/fvl-2023-0102. doi: 10.2217/fvl-2023-0102. Epub 2023 Oct 26. Future Virol. 2023. PMID: 37908844 Free PMC article.
References
-
- WHO Coronavirus (COVID-19) Dashboard | WHO Coronavirus (COVID-19) Dashboard With Vaccination Data. (2021). https://covid19.who.int/
Publication types
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous